Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
93.00    0.00 (0.00%)
Bid:
91.00
Ask:
95.00
Spread: 4.00 (4.396%)
Market Cap: £62.39m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Director/PDMR Shareholding

7 Oct 2011 15:00

7 October 2011

ECO ANIMAL HEALTH GROUP PLC

("the Company")

Reorganisation of employee and director share option scheme and subsequent Directors' Dealing

The Company announces that certain directors have been requested by the board to exercise some of their unapproved share options and they have agreed to commit to the terms, rules and risks of a joint share ownership plan (JSOP), which will also largely replace the directors' remaining, unvested, unapproved share options. The JSOP awards will result in an immediate personal tax charge for each director based on the market value of their part interest in the shares issued, but will more closely align their interests with those of other shareholders, since the directors will only benefit from future gains in the share price above a 5.9% per annum minimum rise. The tax charge and the minimum growth rate represent risks to the participants which were not present in the previously existing unapproved option awards. Furthermore, the new jointly owned shares which replace the exercised options have an additional three year vesting period, while the vested unapproved options might have been exercised at any time. The Company anticipates offering the opportunity to participate in the JSOP to certain senior management in the near future. The total of newly issued jointly owned shares and remaining exercisable options will not be more than the number of options which previously existed and will remain capped at 10% of the number of ordinary shares in issue. A summary of the transactions by directors and resultant holdings is shown below

Name of director No. of options exercised and shares sold Exercise price paid Sale price per share
Marc Loomes 556,110 £1.085 £1.94
Marc Loomes 100,000 £0.85 £1.94

Brett Clemo

32,360

£1.085

£1.94

Brett Clemo 50,000 £0.85 £1.94
Julia Trouse 178,460 £1.085 £1.94
Julia Trouse 50,000 £0.85 £1.94
Kevin Stockdale 22,360 £1.085 £1.94
Kevin Stockdale 50,000 £0.85 £1.94

Name of director Interests in jointly owned shares under the JSOP Subscription price paid by the Employee Benefit Trust Revised holding of interests in jointly owned shares and options
Marc Loomes 906,110 £1.94 933,750
Brett Clemo 282,360 £1.94 310,000
Julia Trouse 393,460 £1.94 421,100
Kevin Stockdale 237,360 £1.94 265,000

Disclosure and Transparency Rules

In accordance with the FSA's Disclosure and Transparency Rules, the Company's issued share capital following the admission of the new 1,819,290 Ordinary Shares will comprise 54,246,451 ordinary shares of 5p with voting rights. These shares are expected to be admitted to trading on 12 October 2011. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Enquiries:

ECO Animal Health Group plc Kevin Stockdale, Finance Director

Peter Lawrence , Chairman

tel: 0208 336 6186

tel: 0208 336 6190

Cenkos Securites plc (Nominated advisor) Elizabeth Bowman tel: 0207 397 8928

Copyright Business Wire 2011

Date   Source Headline
4th Jun 20267:00 amRNSRenewal of revolving credit facility
14th Apr 20267:00 amRNSAppointment of Head of Business Development
31st Mar 20267:00 amRNSBoard Change
19th Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSECOVAXXIN® MG favourable USDA safety assessment
11th Mar 20267:00 amRNSECOVAXXIN®?MG favourable USDA safety assessment
5th Mar 20264:19 pmRNSBlock Listing Return
26th Feb 20267:00 amRNSEU launch plans for ECOVAXXIN® MS
19th Jan 20261:50 pmRNSHolding(s) in Company
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
18th Dec 20257:00 amRNSExercise of Share Options by Director
9th Dec 20255:57 pmRNSHolding(s) in Company
4th Dec 20252:10 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
20th Nov 20259:47 amRNSReplacement: Notice of Results
20th Nov 20257:00 amRNSNotice of Results
10th Nov 20257:00 amRNSEMA Positive Opinion Received for ECOVAXXIN® MS
1st Oct 20257:00 amRNS-RHead of Global R&D
25th Sep 20253:15 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Trading Update and Notice of Interim Results
1st Sep 20257:00 amRNSAppointment of Joint Broker
29th Aug 20257:00 amRNSShare Awards to Executive Directors
28th Aug 20257:48 amRNSPosting of Annual Report and Notice of AGM
21st Aug 202512:29 pmRNSResult of General Meeting
13th Aug 20257:00 amRNSBlock Listing Return
6th Aug 20255:09 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSResults for the year ended 31 March 2025
8th Jul 20254:10 pmRNSNotice of General Meeting and Notice of Results
2nd May 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Update
13th Mar 20257:00 amRNSR&D Day
3rd Mar 20257:00 amRNSSubmission of Marketing Authorisation Application
24th Feb 20254:08 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSDisposal of non-core assets
18th Feb 20257:00 amRNSBlock listing Interim Review
13th Feb 20257:00 amRNSNotice of R&D Day
31st Jan 20257:00 amRNSBoard Changes
20th Dec 20247:00 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:30 pmRNSShare Purchase by Executive Director
28th Nov 20247:00 amRNSResults for the Six Months Ended 30 September 2024
28th Oct 202412:57 pmRNSShare Awards to Executive Directors
22nd Oct 202411:00 amRNSEBT Share Purchase
21st Oct 20247:00 amRNSEBT Share Purchase
14th Oct 202411:07 amRNSEBT Share Purchase
9th Oct 20247:00 amRNSIssue of Equity and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.